Gemcitabine doublets in advanced urothelial cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine doublets in advanced urothelial cancer

Published:2002-02 Issue:1 Volume:29 Page:15-19
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Stadler Walter M

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference37 articles.

1. Gemcitabine in locally advanced and/or metastatic bladder cancer;von der Maase;Crit Rev Oncol Hematol,2000

2. Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer;Stadler;J Clin Oncol,1997

3. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol,1988

4. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors;Logothetis;J Clin Oncol,1990

5. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study;Loehrer;J Clin Oncol,1992

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers;Life;2023-06-01

2. Gemcitabine?Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 Patients;The Breast Journal;2007-03

3. Chemotherapy for Bladder Cancer: Treatment Guidelines for Neoadjuvant Chemotherapy, Bladder Preservation, Adjuvant Chemotherapy, and Metastatic Cancer;Urology;2007-01

4. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch;Proceedings of the National Academy of Sciences;2006-10-20

5. Muscle invasive and metastatic bladder cancer;Annals of Oncology;2006-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3